Investigator Agreement Template for Malaysia
Generate a bespoke document
What is a Investigator Agreement?
The Investigator Agreement serves as the primary contract governing the relationship between research sponsors/institutions and medical investigators conducting clinical trials in Malaysia. This document is essential when engaging qualified medical professionals to conduct clinical research, ensuring compliance with Malaysian regulatory requirements, including the Clinical Trial Regulation 2018 and Malaysian Guidelines for Good Clinical Practice. The agreement comprehensively addresses key aspects such as protocol adherence, patient safety, data collection, confidentiality, and compensation, while incorporating specific Malaysian legal and regulatory requirements. It's particularly crucial for pharmaceutical companies, research organizations, and healthcare institutions conducting clinical trials in Malaysia, providing a clear framework for responsibilities, obligations, and compliance requirements.
Trusted by high-performance teams
About the Investigator Agreement
An Investigator Agreement is a crucial legal contract that governs the relationship between research sponsors and medical investigators conducting clinical trials in Malaysia. This document ensures that clinical research is conducted ethically, safely, and in full compliance with Malaysian regulatory requirements, including the Clinical Trial Regulation 2018 and Malaysian Guidelines for Good Clinical Practice.
When do you need this document?
You need an Investigator Agreement whenever you engage a medical professional to conduct clinical research in Malaysia. This includes pharmaceutical companies hiring principal investigators for drug trials, contract research organizations working with hospital-based researchers, universities collaborating with medical centers on research studies, and healthcare institutions establishing relationships with external investigators. The agreement is mandatory before any clinical trial activities commence and must be executed prior to patient enrollment or data collection.
Key legal considerations
Several critical legal elements must be addressed in your Investigator Agreement. The scope of services section should clearly define the investigator's responsibilities, including patient recruitment, protocol compliance, adverse event reporting, and data collection obligations. Compliance clauses must reference adherence to Malaysian laws, Good Clinical Practice guidelines, and ethical standards. Confidentiality provisions are essential for protecting proprietary information and patient data in accordance with the Personal Data Protection Act 2010. The agreement should also address compensation terms, intellectual property rights, indemnification clauses, and termination conditions. Insurance and liability provisions protect both parties from potential claims arising from the research activities.
Legal requirements in Malaysia
Malaysian law imposes specific requirements that must be incorporated into your Investigator Agreement. The Clinical Trial Regulation 2018 mandates that investigators possess appropriate qualifications and experience, maintain detailed records, and report adverse events within prescribed timeframes. The Medical Act 1971 establishes professional standards for medical practitioners conducting research, requiring valid medical licenses and adherence to professional conduct standards. Personal data protection obligations under the Personal Data Protection Act 2010 require explicit consent mechanisms, data security measures, and disclosure limitations when handling patient information. The agreement must also comply with the Contracts Act 1950 for validity and enforceability, including proper consideration, legal capacity of parties, and lawful objectives. Additionally, Malaysian Guidelines for Good Clinical Practice must be explicitly referenced and incorporated to ensure research quality and patient safety standards are maintained throughout the study duration.
GOVERNING LAW
Applicable law
This Investigator Agreement is drafted to comply with Malaysia law. Key legislation includes:
Medical Act 1971: Establishes the legal framework for medical practice in Malaysia, including professional standards and requirements for medical practitioners conducting research
Personal Data Protection Act 2010: Regulates the collection, use, and disclosure of personal data, particularly relevant for handling patient information in clinical trials
Contracts Act 1950: Provides the basic legal framework for contract formation and enforcement in Malaysia, essential for the validity of the agreement
Malaysian Guidelines for Good Clinical Practice (GCP): Establishes standards for conducting clinical trials and research, including investigator responsibilities and ethical requirements
Patents Act 1983: Governs intellectual property rights related to research discoveries and innovations
Medicines (Advertisement and Sale) Act 1956: Regulates the advertising and sale of medicines, relevant for clinical trials involving pharmaceutical products
Poisons Act 1952: Controls the use and handling of pharmaceutical substances in research and clinical trials
Explore 208,390+ legal templates
Explore 208,390+ legal templates
Genie's Security Promise
Genie is the safest place to draft. Here's how we prioritise your privacy and security.
Your data is private:
We do not train on your data; Genie's AI improves independently
All data stored on Genie is private to your organisation
Your documents are protected:
Your documents are protected by ultra-secure 256-bit encryption
We are ISO27001 certified, so your data is secure
Organizational security:
You retain IP ownership of your documents and their information
You have full control over your data and who gets to see it

